BriaCell Therapeutics Cor... (BCTX)
NASDAQ: BCTX
· Real-Time Price · USD
12.32
0.60 (5.12%)
At close: Oct 16, 2025, 3:59 PM
12.31
-0.08%
After-hours: Oct 16, 2025, 07:36 PM EDT
5.12% (1D)
| Bid | 12.12 |
| Market Cap | 21.62M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -19.43M |
| EPS (ttm) | -76.9 |
| PE Ratio (ttm) | -0.16 |
| Forward PE | -0.72 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 12.75 |
| Volume | 53,437 |
| Avg. Volume (20D) | 82,595 |
| Open | 11.94 |
| Previous Close | 11.72 |
| Day's Range | 11.80 - 12.76 |
| 52-Week Range | 3.50 - 98.20 |
| Beta | 1.62 |
| Ex-Dividend Date | n/a |
About BCTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BCTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BCTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsBriaCell Therapeutics Corp. is scheduled to release its earnings on
Oct 28, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+9.61%
BriaCell Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
3 months ago
-61.78%
BriaCell Therapeutics shares are trading lower after the company announced the pricing of a $15 million offering of 12 million units at $1.25 per unit.
